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DICER is a central regulator of microRNAmaturation.
However, little is known about mechanisms regu-
lating its expression in development or disease.
While profiling miRNA expression in differentiat-
ing melanocytes, two populations were observed:
some upregulated at the pre-miRNA stage, and
others upregulated as mature miRNAs (with stable
pre-miRNA levels). Conversion of pre-miRNAs to
fully processed miRNAs appeared to be dependent
upon stimulation of DICER expression—an event
found to occur via direct transcriptional targeting
of DICER by the melanocyte master transcriptional
regulator MITF. MITF binds and activates a con-
served regulatory element upstream of DICER’s
transcriptional start site upon melanocyte differenti-
ation. Targeted KOof DICER is lethal tomelanocytes,
at least partly via DICER-dependent processing of
the pre-miRNA-1792 cluster thus targeting BIM,
a known proapoptotic regulator of melanocyte
survival. These observations highlight a central
mechanism underlying lineage-specific miRNA regu-
lation which could exist for other cell types during
development.INTRODUCTION
MicroRNAs (miRNAs) are short noncoding RNAs that inhibit
mRNA translation or stability (Carthew and Sontheimer, 2009;994 Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc.Du and Zamore, 2007; Filipowicz et al., 2008; Maroney et al.,
2006; Neilson and Sharp, 2008; Schier and Giraldez, 2006).
Numerous fundamental processes, including development,
differentiation, and tumorigenesis, are regulated by miRNAs
(Calin and Croce, 2006; Chang and Mendell, 2007; Ma and
Weinberg, 2008; Medina and Slack, 2008; Schickel et al., 2008).
Functional mature miRNAs arise through several posttran-
scriptional processing steps which include cleavage by Dro-
sha/DGCR8 to pre-miRNA, export, and digestion by the RNase
III endonuclease DICER, which also mediates loading onto
RISC complexes (Bushati and Cohen, 2007; Filipowicz et al.,
2008; Kim et al., 2009; Schickel et al., 2008; Winter et al.,
2009; Zeng and Cullen, 2006). Even though a group of miRNAs
called mirtrons can bypass Drosha by instead using the splicing
machinery (Berezikov et al., 2007; Ruby et al., 2007), there is no
evidence of DICER-independent miRNAs, suggesting that
DICER is indispensable for miRNA biogenesis.
DICER activity is regulated by cofactors such as TRBP (TAR
RNA-binding protein), PACT (PKR activator) and KH-type
splicing regulatory protein (KSRP) (Chendrimada et al., 2005;
Haase et al., 2005; Jaskiewicz and Filipowicz, 2008; Lee et al.,
2006; Trabucchi et al., 2009), as well as by an ATP mediated
control of its helicase/ATPase domain (Asada et al., 2008;
Bernstein et al., 2001; Liu et al., 2003 ; Zhang et al., 2002). DICER
regulation has been explored in development where it may be
differentially expressed and localized within the cell (Barbato
et al., 2007). Studies show posttranscriptional regulation of
miRNA at the DICER level during development, via either differen-
tial expression or activity of DICER (Obernosterer et al., 2006;
Wulczyn et al., 2007). DICER cleavage activity and mature-
miRNA expression in mammals are restricted to certain tissues
and cell types, suggesting tissue-specific regulation of its activity
(Obernosterer et al., 2006). Transcriptional regulation of DICER
Figure 1. MicroRNA Expression Profile upon Melanocyte Stimula-
tion by Forskolin
Primary human melanocytes were serum depleted for 12 hr, followed by treat-
ment with 20 mM forsk (or DMSO control) for 16 hr. Total RNA was harvested,
and miRNA expression array analysis was performed. Fold-changes between
paired control and activated samples were ranked, and p values for the rank
distribution of fold-changes corresponding to given miRNAs were computed
using the hypergeometric test. The figure shows the ranked log-transformed
p-values of upregulated (yellow) and downregulated miRNAs (cyan). A full
list of differentially regulated miRNAs can be found in Table S1.expression remains incompletely understood. Mammalian
genomes encode one DICER gene with two alternative 50 UTRs
(the coding regions are similar) (Jaskiewicz and Filipowicz, 2008).
Microphthalmia-associated transcription factor (MITF) is a
tissue-restricted master regulator of melanocytes, and is essen-
tial for their proliferation, survival, and differentiation (Levy et al.,
2006). Melanocyte differentiation/pigmentation is stimulated
by Melanocyte Stimulating Hormone (MSH). MSH binds the
Melanocortin Receptor 1 (MC1R) to stimulate cAMP production,
which in turn activates CREB/ATF1 to transcribe MITF, which
transcriptionally targets numerous genes associated with mela-
nocyte differentiation (Levy et al., 2006). The sun-tanning
pigment response is associated with keratinocyte DNA damage,
followed by p53-mediated induction of MSH expression and
secretion (Cui et al., 2007). Human redheads typically harbor
variant forms of MC1R that cannot respond to MSH, thus
likely explaining their poor or absent tanning response (Lin and
Fisher, 2007). Of note, topical administration of the adenylate
cyclase agonist forskolin (forsk) was shown to ‘‘rescue’’ this
pathway in a mouse mc1r ‘‘redhead’’ model, inducing strong
melanin synthesis, skin darkening, and UV photo-protection
(D’Orazio et al., 2006). Forsk can thus serve as a means to induce
melanocytic differentiation, even in cells harboring nonrespon-
sive MC1R variants.
MITF also plays a vital role in lineage survival, and MITF muta-
tion in numerous species (including humans) results in major loss
of melanocyte viability. Correspondingly MITF appears to be
an amplified oncogene in a fraction of human melanomas
(Garraway et al., 2005). The profound resistance of melanomas
to numerous triggers of apoptosis (including cytotoxic chemo-
therapy) is incompletely understood, but may involve lineage
specific survival mechanisms. For example BCL-2, a direct tran-
scriptional target of MITF, is required for melanocyte survival,
based upon loss of the melanocyte lineage in Bcl-2 null mice
(Kamada et al., 1995; Veis et al., 1993; Yamamura et al., 1996),
thus linking lineage-specific transcriptional control of pigmenta-
tion to survival (McGill et al., 2002). The BCL-2 family regulates
apoptosis propensity in many contexts (Youle and Strasser,
2008). Prosurvival (antiapoptotic) members of the family include
BCL-2 while proapoptotic members include BIM (Cartlidge et al.,
2008; Ewings et al., 2007; O’Connor et al., 1998). Whereas Bcl-2
KO mice display premature de-pigmentation due to melanocyte
apoptosis (Nishimura et al., 2005; Veis et al., 1993), additional
deletion of both BIM alleles prevents this defect, restoring
pigmentation (Bouillet et al., 2001). This finding places BIM as
a critical player in the regulation of melanocyte apoptosis and
possibly also of melanomagenesis.
Expression and proapoptotic activity of BIM are regulated by
several different signaling systems, including the ERK, p38 and
JNK MAP kinase pathways, via transcriptional and posttran-
scriptional mechanisms (Cai et al., 2006; Cartlidge et al., 2008;
Ewings et al., 2007; Ley et al., 2005; O’Connor et al., 1998).
miRNAs also take part in posttranscriptional regulation of BIM.
Multiple studies have shown that the miRNA-1792 cluster
directly targets BIM, and that downregulation of BIM expression
is tumorigenic and affects normal development of many tissues
(Fontana et al., 2008; Koralov et al., 2008; Mendell, 2008; Ventura
et al., 2008; Xiao et al., 2008).Here we observe that DICER expression is strongly induced
during melanocyte differentiation via direct transcriptional regu-
lation by MITF. Through miRNA profiling we identify one class of
miRNAs upregulated at the pre-miRNA level and one class upre-
gulated as mature-miRNAs (with unchanged pre-miRNA). The
latter class appears to reflect DICER induction during lineage
differentiation. We also demonstrate that DICER KO is lethal to
melanocytes both in-vivo and in-vitro, and may involve posttran-
scriptional processing of the miR-1792 cluster targeting BIM.
RESULTS
miRNA Expression Profiles in Melanocytes
To assess expression changes in miRNAs during melanocyte
differentiation, we utilized human primary melanocytes gener-
ated from discarded foreskin tissue. Since the donor’s genetic
background is unknown and therefore the responsiveness of
MC1R to MSH may be variable, we stimulated the cells with
forsk, which directly activates adenyl cyclase, thus mimicking
a key step in the pigmentation/differentiation pathway. Human
primary melanocytes from seven different donors were stimu-
lated with forsk for 16 hr. Induction of differentiation was
confirmed by documenting upregulation of MITF and known
MITF transcriptional target genes by forsk (Bertolotto et al.,
1998; Price et al., 1998) (data not shown; see below). Once vali-
dated, the treated and vehicle-control treated cultures were
subjected to miRNA expression profiling. The distribution of
expression values for each miRNA in the differentiated versus
resting cell groups was compared using several statistical tests
(Figure 1 and Table S1 available online). We further investigated
the levels of both primary and mature miRNAs upon treatment
with forsk.Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc. 995
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B Figure 2. miRNA1792 Cluster Is Posttran-
scriptionally Regulated upon Melanocyte
Stimulation
(A) Primary human melanocytes were stimulated
with forsk for the indicated times and then total
RNA was harvested for qRT-PCR analysis,
mature-miRNA expression (Red) and pre-miRNA
gene expression (Blue). Mature-miRNAs were
normalized to RNU48 and pre-miRNAs to Actin
and are presented relative to nonstimulated cells.
Error bars indicate mean ± SD of five independent
experiments from different primary melanocyte
donors.
(B) Total RNA from primary melanocytes treated
as in (A) subjected to Northern blot analysis.
Band intensity was normalized to tRNA and pre-
sented as fold-induction.
(C) Similar qRT-PCR analysis was performed on
16 different miRNAs. The table presents the
indicated mature-miRNA and pre-miRNA expres-
sion status upon melanocyte stimulation. An
arrow indicates upregulation and a line represents
no change in the gene expression. Detailed pre-
miRNA expression patterns upon melanocyte
stimulation can be found in Figure S1 and
Figure S2.As shown in Figure 2, we utilized qRT-PCR and Northern
blot analyses to examine both pre-miRNA and mature miRNA
levels. One notable set of miRNAs was miR-17-3p and miR-
92a, both of which belong to the same miRNA cluster. Mature
and pre levels of all six miR-1792 cluster members were
analyzed. Four of the six showed induction upon melanocyte
differentiation and the largest changes were observed for miR-
17-3p and miR-92 (Figure S1). We also measured miR-211
levels, as it is an intronic miRNA hosted by the known MITF
target gene TRPM1 (Miller et al., 2004) and, therefore, is likely
to be transcriptionally regulated by MITF. Increases in mature
miR-17-3p, miR-92a and miR-211 were seen at 4 or 14 hr of
stimulation; however, among the precursor forms, only pre-
miR-211 levels were increased, while no significant change was
observed in pre-miR-17-3p or pre-miR-92a (Figure 2A and B).
Upregulation of mature miRNAs, without an accompanying
increase in the pre-miRNA level, suggested posttranscriptional
regulation of these miRNAs. To assess if such posttranscrip-
tional modulation was unique to miR-17 in melanocytes, we
similarly examined precursor levels for 16 miRNAs that were
differentially expressed at the 5% significance level of both996 Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc.hypergeometric test and t test. We
observed that seven of the 16 miRNAs
(43%) were similarly upregulated post-
transcriptionally (but not at the pre-
miRNA level), suggesting that this mode
of regulation may be relatively common
(Figure 2C, Figure S2, and Figure S3D).
There are several potential mechanisms
that could explain this, including altered
DICER level, DROSHA complex activity,
and pre-miRNA export or stability. Wetherefore examined the expression of DICER and DROSHA
during melanocyte differentiation.
DICER Protein and RNA Levels Are Upregulated during
Melanocyte Differentiation
Upon differentiation of melanocytes with either aMSH or forsk,
phosphorylation of CREB is observed, followed by upregulation
of MITF expression (Price et al., 1998) (Figures 3A and 3B). We
observed a striking increase in DICER protein level in stimulated
human primary melanocytes, which occurred shortly after upre-
gulation of MITF. Levels of DROSHA protein did not change upon
melanocyte stimulation (Figure 3A). In addition to elevated
protein levels, DICER mRNA levels also increased upon melano-
cyte differentiation (Figure 3C and Figure S3A), consistent with
the possibility that DICER may be transcriptionally upregulated
during melanocyte differentiation.
To test whether DICER upregulation by forsk/cAMP signaling
is a ubiquitous phenomenon, we compared regulation of DICER
expression by forsk in both human primary fibroblasts and mela-
nocytes generated from five different donors. Both cell types
were stimulated with forsk followed by total RNA and protein
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Figure 3. Lineage-Specific DICER Upregulation
upon Melanocyte Stimulation
(A and B) Primary human melanocytes were stimulated
with forsk or aMSH for the indicated times and harvested
for immunoblot analysis using monoclonal antibodies.
Tubulin was used as loading control.
(C) Primary human melanocytes or primary human fibro-
blasts were stimulated with forsk for the indicated times
and harvested for immunoblot and qRT-PCR analysis.
Tubulin was the loading control. mRNA expression results
were normalized to Actin and are relative to nonstimulated
() values. The data show fold of stimulation and represent
mean ± SD of 3 experiments performed in triplicate. See
also Figure S3.analyses. No increase in DICER protein or RNA level was
observed in the treated fibroblasts (Figure 3C right panel) despite
upregulation of pCREB. Thus DICER upregulation seen in mela-
nocytes upon forsk treatment does not occur in other cell line-
ages and may therefore utilize lineage specific functional inter-
mediate(s).
DICER Upregulation Is MITF-Dependent
The possibility that DICER regulation in response to cAMP
signaling is lineage specific led us to explore the possibility
that MITF may directly upregulate DICER. Human primary mela-
nocytes were transfected with siRNA targeting MITF (or control
siRNA) prior to forsk treatment (Figure 4A). Differentiation of
primary melanocytes led to 5- and 3-fold increases in MITF
and DICER mRNA levels respectively. In contrast, introduction
of siMITF blunted upregulation of MITF levels and resulted inCell 141,virtually no induction of DICER mRNA. More-
over, upregulation of miRNAs 17 and 92
upon forsk stimulation was seen to be MITF
dependent (Figure S3B). As a complementary
approach, we also utilized adenoviruses encod-
ing either nuclear-targeted GFP (control), wild-
type (wt) MITF, or dominant-negative (dn) MITF,
followed by forsk treatment. These adenoviral
vectors have previously been shown to effi-
ciently modulate MITF activity (McGill et al.,
2002). In differentiating melanocytes, dnMITF
significantly blocked DICER upregulation upon
forsk stimulation. In addition, melanocytes that
were infected with wt MITF showed significantly
higher levels of endogenous DICER, even
without stimulation, relative to controls, whereas
dnMITF did not appear to affect basal DICER
levels (Figure 4B). These data suggest that
MITF resides upstream in the transcriptional
regulation of DICER expression during differen-
tiation of primary human melanocytes.
MITF Regulation of the DICER Promoter
Examining the DICER promoter in both human
and mouse revealed two conserved E-box
elements, the MITF consensus binding se-
quences, within 2 kb upstream of the DICER
transcription start site (Figure 4C). Chromatin immunoprecipita-
tion generated from activated and resting primary melanocytes
revealed forsk-induced occupancy of the DICER promoter by
MITF upon stimulation. The same anti-MITF antibody showed
no binding to a downstream region of the DICER gene, while
binding was detected upstream of the known MITF target
gene for tyrosinase (positive control) (Yasumoto et al., 1994)
(Figure 4D). In addition, a luciferase reporter driven by the DICER
promoter region exhibited MITF responsiveness which was lost
upon mutation of either of the two E-box elements, although a
stronger affect was observed when the more upstream E-box
was mutated. Moreover activity of the same reporter was
suppressed upon introduction of siMITF, also in an E-box depen-
dent fashion (Figure 4E). These results indicate that MITF
occupies and may directly regulate the endogenous DICER
promoter.994–1005, June 11, 2010 ª2010 Elsevier Inc. 997
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Figure 4. DICER Is an MITF Target Gene
(A) Primary human melanocytes were transfected with siMITF or scrambled siRNA. At 48 hr posttransfection, cells were serum-depleted for 12 hr, followed by
forsk stimulation. Total RNA from stimulated melanocytes was used for qRT-PCR analysis. Graphs present MITF (upper) or DICER (lower) mRNA levels upon
stimulation, in either siMITF-transfected cells (dash bars) or cells transfected with control siRNA (full bars). Results are normalized to Actin and are relative to
non stimulated () values. The data show fold of induction relative to siCont and represent mean ± SD of five replicates.
(B) Primary human melanocytes were infected with either MITF wild-type (wt), MITF dominant-negative (dn) or empty vector adenovirus (MOI:200). 72 hr postinfec-
tion, cells were serum-depleted for 12 hr, stimulated with forsk for the indicated time, and harvested for immunoblot analysis. Tubulin was used as loading control.
(C) Diagram of the human DICER gene promoter region showing two putative MITF binding sites (filled gray boxes) at positions 2323 and 928 nucleotides
upstream of the transcription start site.
(D) Binding of MITF to the endogenous DICER promoter region in forsk activated and resting (-) primary human melanocytes. Chromatin immunoprecipitations
were performed using log-phase primary human melanocytes. Protein:chromatin-crosslinked complexes were immunoprecipitated with either MITF antibody or
control antibody. PCR primers spanning either DICER promoter (‘‘pro’’) or downstream (‘‘down’’) regions were employed. Tyrosinase promoter (‘‘Tyr pro’’)
primers were used as a positive control. The data show promoter occupancy relative to control Ab and represent mean ± SD of 3 independent experiments.
(E) UACC62 melanoma cells were transiently transfected with DICER promoter reporter plasmids, in addition to siMITF, control siRNA, overexpression vector for
MITF, or empty vector. The same set of experiments was performed on DICER promoter wt, mutated E-boxes or empty reporter plasmids as indicated. After
48h, firefly luciferase was measured and normalized to renilla luciferase (transfection control). The data show fold of stimulation and represent mean ± SD of
three experiments performed in triplicate.MITF and DICER Expression Correlate In Vivo
If MITF were transcriptionally regulating DICER, then DICER
levels might parallel MITF in melanocytes in vivo. To test this,
we examined skin from mutant mice (mitfwh/+) heterozygous for
a dominant negative allele of Mitf, with the resulting Mitf net
activity <50% of normal (Steingrimsson et al., 1994). Fur on these
mice (on a C57BL/6 background) appears homogeneously
grayish in color (Figure 5A). The coat color is due to a distinct
pigment/color on each hair, and is not due to a mixture of black
and white hairs (D.E.F., K. Wakamatsu, S. Ito, unpublished data).
Moreover, the color pattern is stable and not associated with
progressive whitening (or progressive melanocyte cell death,
data not shown). We carried out three-color immunofluores-
cence staining for Mitf, Dicer, and DAPI (multiple independent998 Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc.skin sections per mouse), and quantified the staining intensity
by normalizing the Dicer signal to DAPI from the same cells
(Figure 5B and Figure S4A). In mitfwh/+ heterozygotes, we
observed a significant decrease in Dicer within melanocytes
(identified as Mitf positive) as compared to Dicer expression in
melanocytes of Mitf wt (mitf+/+) littermates, normalized to DAPI
in the same cells. As a control, the identical analysis was carried
out in adjacent keratinocytes (identified by their location within
hair follicles and Mitf negativity). In keratinocytes no significant
difference in Dicer expression was observed between mitfwh/+
and mitf+/+ genetic backgrounds (Figure 5B and Figure S4A).
To further study the expression of Dicer and Mitf in vivo, we
examined melanocyte stem cells and differentiated melanocytes
in C57BL/6 hair follicles. These melanocyte subpopulations were
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Figure 5. MITF and DICER Expression
Levels Correlate In Vivo
(A) Dorsal view of MITF (mitfwh/+) heterozygote
mice compared to wt MITF (mitf+/+) mice, indi-
cating altered pigmentation (which does not
change upon aging).
(B) DICER expression intensity in hair follicle mela-
nocytes and keratinocytes was measured by
immunofluorescence staining of the indicated
mouse skin sections (see also Figure S4). DICER
intensity expression level was normalized to
DAPI staining and plotted.
(C) Three-color coimmunofluorescence staining of
C57BL/6 skin sections indicates expression of
DICER (green, cytoplasmic), MITF (red, nuclear)
and DAPI (blue, nuclear) (400x magnification).
MITF-stained differentiated melanocytes and
melanocyte stem cells, both appear red (arrows).
The merged image shows colocalization of DICER
and MITF in melanocytes (‘‘merge’’). DICER and
MITF staining intensities in melanocyte stem cells
and differentiated melanocytes were measured
(circled areas), normalized to DAPI staining, and
plotted.
(D) MITF and DICER mRNA levels in primary human
melanocytes from 10 different donors. HDAC1 was
used as a control gene, expression levels were
relative to Actin. Expression values for each gene
were normalized to a mean of zero and a standard
deviation of one. See also Figure S4.studied because Mitf and its melanogenic target genes are upre-
gulated in the differentiated versus stem-cell populations
(Osawa et al., 2005), and because these populations can be
discriminated by their distinct locations within the follicles
(bulge versus bulb regions) (Nishimura et al., 2005). Similar to
the three-color quantitative immunofluorescence technique
used in Figure 5B, increased levels of both Mitf and Dicer were
seen in differentiated melanocytes as compared to melanocyte
stem cells (Figure 5C), consistent with the possibility that Mitf
could regulate Dicer expression within the melanocyte lineage
in vivo.
We also checked the correlation of MITF and DICER mRNA
levels by performing qRT-PCR for MITF and DICER on a series
of human primary melanocyte cultures generated from 10
different donors. Expression levels of MITF and DICER were
normalized to b-actin and compared (Figure 5D). Highly parallel
expression patterns were observed for MITF and DICER mRNAs
in primary melanocytes, but not for a control gene (histone
deacetylase 1 [HDAC1]). The parallel expression patterns are
consistent with the hypothesis that MITF modulates DICER
expression.Cell 141, 994–10Targeted DICER Knockout Results
in Epidermal and Hair Follicle
Melanocyte Depletion
Since a tight correlation between DICER
and MITF expression was observed
in vivo, we chose to study the physiologic
significance of DICER in melanocytes
in vivo, utilizing a conditional KO strategy.Mice harboring the floxed (fl) Dicer1 allele (Harfe et al., 2005)
were bred to mice expressing Cre recombinase driven by the
Tyrosinase (Tyr) promoter, which triggers ablation of floxed
exons in melanocytes and melanoblasts (Delmas et al., 2003).
A Dct-LacZ transgene was also incorporated (Mackenzie et al.,
1997) to mark the melanocyte lineage.
Newborn litters were of the expected size and Mendelian
ratios, and appeared to have normal skin and formation of hair
follicles irrespective of Dicer expression. As shown in Figure 6A
the homozygous Dicer(fl/fl); Tyr::Cre; Dct-lacZ/ mice were easily
distinguishable from the Dicer(fl/+); Tyr::Cre; Dct-lacZ/ control
littermates, as they were virtually white from birth, except for
the tips of the initial hairs on the dorsal trunk, and completely
white after the first hair follicle cycle. Histopathologic analysis
revealed no melanin in the skin of P30 Dicer(fl/fl); Tyr::Cre; Dct-
lacZ/ mice as compared to Dicer(fl/+); Tyr::Cre; Dct-lacZ/
control littermates (Figure 6B).
Profound loss of both melanocyte stem cells and differentiated
melanocytes was observed by X-gal staining of skin sections
and whole mount staining of homozygous Dicer(fl/fl); Tyr::Cre;
Dct-lacZ/ mice, compared to heterozygote Dicer(fl/+); Tyr::Cre;05, June 11, 2010 ª2010 Elsevier Inc. 999
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Figure 6. Conditional Knockout of DICER in Melanocytes Leads to Melanocyte Loss
(A) Tyr-Cre mediated recombination of theDicerflox allele in the melanocyte lineage. Homozygous Dicer conditional knockouts (KO) are compared to heterozygote
littermates. Dorsal and ventral P2, P23, and P30 view of the indicated littermates.
(B) Fontana-Masson staining of melanin (upper) shows skin regions of the indicated littermates. Blue X-gal staining (middle row) of P42 littermate hair follicles
revealed the presence of Dct-lacZ labeled melanocytes (arrows) in the indicated mouse skin sections. Whole mount blue X-gal staining (lower) indicates Dct-lacZ
labeled melanocyte stem-cells (arrows) and differentiated melanocytes (circled) in skin sections of control Dicer(fl/+); Tyr::Cre; Dct-lacZ/ mice, but not in homo-
zygously deleted mice.
(C) Immunofluorescence staining of P42 skin sections indicates expression of MITF (red, nuclear) (4003magnification). MITF-stained melanocyte stem-cells and
differentiated melanocyte are indicated within hair follicles of control mice, but are absent from Dicer(fl/fl); Tyr::Cre; Dct-lacZ/ mice. DAPI-stained nuclei appear
blue. See also Figure S5, Figure S6, and Figure S7.Dct-lacZ/ littermate controls (Figure 6B). Skin sections of
6 week old (P42) mice were also subjected to immunostaining,
using Mitf (red) as a melanocytic marker. As shown in Figure 6C
no melanocyte/Mitf immunoreactivity was present in the homo-
zygous Dicer(fl/fl); Tyr::Cre; Dct-lacZ/ mice, compared to
heterozygous Dicer(fl/+); Tyr::Cre; Dct-lacZ/ control littermates.
Multiple melanocyte markers (Dct-LacZ and Mitf) demonstrated
that Dicer deficiency produces coat color depigmentation due to
melanocyte loss, rather than absence of pigment within viable
melanocytes. Thus Dicer deficiency significantly phenocopies
the melanocyte survival phenotype of Mitf deficiency (it is uncer-
tain whether the slightly later age of melanocyte disappearance
in Dicer(fl/fl); Tyr::Cre mice relative to severe mitf mutants is due
to delayed Dicer gene-deletion in this nongermline KO model or
age-specific requirement for Dicer activity).
Two additional Cre recombinase-targeted mouse models
were also generated, by breeding Dicer(fl/fl) mice to Cre recom-
binase driven by the dopachrome tautomerase (Dct) promoter1000 Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc.(Guyonneau et al., 2004) or a 4-hydroxytamoxifen (OHT)-induc-
ible Cre recombinase-estrogen receptor fusion transgene under
the control of the tyrosinase promoter, designated Tyr::CreERt2
(Bosenberg et al., 2006). The Dct-CRE allele resulted in modest
fur depigmentation from birth followed by progressive age-
dependent depigmentation (Figures S5A–S5D). To test require-
ments for Dicer within epidermal (rather than hair follicle) melano-
cytes, the Dct-CRE allele was also crossed onto the Dicer(fl/fl);
K14-SCF transgenic background (which contains epidermal
melanocytes due to keratin-14 promoter driven expression of
Stem Cell Factor [Kunisada et al., 1998]). Unlike darkly pig-
mented epidermis in control (Dicer(fl/+); Dct-Cre; K14-SCF;
Dct-lacZ/) littermates, homozygous mutant (Dicer(fl/fl); Dct-
Cre; K14-SCF; Dct-lacZ/) mice exhibited significant epidermal
lightening (Figure S5B). The inducible Cre system utilized
topical OH-tamoxifen administration on postnatal days 2–5
and resulted in a white phenotype in the treated region (with
normal black pigmentation remaining in the adjacent area) and
fur depigmentation seen at day P32 (Figure S6A, compare
Dicer(fl/fl); Tyr::CreER; Dct-lacZ mice to Dicer(fl/+);TyR::CreER;
Dct-lacZ control littermates). As with Dicer(fl/fl); Tyr::Cre mice,
histologic analyses of the postnatal/progressive CRE-induced
Dicer deletion models demonstrated that the depigmentation
was associated with melanocyte cell loss (rather than absence
of pigment within viable melanocytes) (Figures S5E and S5F
and Figure S6B). Collectively these data demonstrate an essen-
tial role for Dicer in regulating viability of the melanocyte lineage
postnatally as well as in earlier developmental stages.
In addition, primary mouse melanocyte cultures were gener-
ated from Dicer (fl/fl) mice and exposed to exogenous Cre-
adenovirus. In this fashion complete excision of Dicer was
induced, resulting in miRNA loss and death of melanocytes
(Figures S6C–S6G). Similarly, siRNA-mediated DICER knock-
down (KD) (Figure S7A) in primary human melanocytes also
resulted in a decrease in miRNA expression (Figure S7B) as
well as melanocyte cell death (Figures S7C and S7D). These
results reveal an essential role of DICER in both human and
mouse melanocyte survival.
Regulation of miR-17 and BIM by DICER during
Melanocyte Differentiation
DICER’s survival role in melanocytes may be mediated by
multiple miRNAs, but we attempted to identify one such DICER-
processed miRNA which may contribute functionally to this
viability phenotype. The proapoptotic factor BIM (BCL2L11, Iso-
forms 1 and 6 but not Isoform 9) was previously found to be a
direct target of the miRNA-1792 cluster (Fontana et al., 2008;
Koralov et al., 2008; Ventura et al., 2008; Xiao et al., 2008).
BIM has been shown to play a critical role in melanocyte survival,
since BIM germline deletion profoundly rescues melanocytic cell
death (coat-color) in the absence of Bcl-2 (Bouillet et al., 2001).
In parallel to the miRNA expression profile, total RNA from stim-
ulated melanocytes was subject to mRNA profiling. We found
that miR-17 upregulation in differentiated melanocytes (Figure 2)
correlated with BIM mRNA downregulation (Figure S3C).
TUNEL assay demonstrated that KD of DICER resulted in
significant loss of melanocytes (Figure 7B and Figure S7).
Reconstitution of miR-17 or KD of BIM with siBIM in DICER KD
cells significantly (albeit incompletely) rescued melanocyte
survival/apoptosis (Figures 7A–7C). miR-17 targeting of BIM
may play a significant role in lineage survival, although it is likely
that other miRNAs as well as apoptotic regulators also contribute
to control of melanocytic survival.
DISCUSSION
We have identified a novel mechanism of DICER upregulation via
its transcriptional targeting by the melanocytic transcription
factor MITF during differentiation. We also demonstrate that
DICER plays a crucial role in melanocyte survival involving, in
part, posttranscriptional processing of miR-17 which leads to
downregulation of the proapoptotic protein BIM.
Although it is well known that DICER is ubiquitously expressed
among many cell types, regulation of its expression may control
miRNA biogenesis in specific cellular contexts. It is plausible that
DICER induction may be important for additional differentiation-specific activities, such as melanin production, maturation, or
export. However, it is also notable that MITF exhibits oncogenic
activity in at least two human malignancies: melanoma (where it
is amplified in 10%–20% of cases) and Clear Cell Sarcoma
(where it is activated by the EWS-ATF1 chimeric oncoprotein)
(Davis et al., 2006; Garraway et al., 2005). Modulation of melano-
cyte survival via upregulation of DICER and miR-17, followed
by suppression of BIM, may thus contribute to tumor survival,
especially since BIM has been shown to play a vital role in
mediating melanocytic cell death upon Bcl-2 deletion (Bouillet
et al., 2001).
MITF regulates gene expression by binding to DNA as a
homodimer or as a heterodimer with Tfe3, Tfeb, or Tfec proteins
(MiT family). All these family members, bind to identical DNA
sequences (Hemesath et al., 1994; Levy et al., 2006; Steingrims-
son et al., 2004). Although MITF expression seems to be
restricted to specific cell types, other members of the MiT family
are thought to be more ubiquitously expressed. Therefore, it will
be important to examine potential participation of the other MiT
family members in DICER regulation in the context of other
tissues and cell types. It was previously shown that DICER
cleavage activity is restricted to certain tissues and cell types,
albeit by an unknown mechanism (Obernosterer et al., 2006).
Here, we report that transcriptional upregulation of DICER
occurs during melanocyte differentiation due to direct targeting
by MITF. These data thus highlight a prospective role of DICER
and miRNAs in skin adaptation to sun exposure.
DICER and Melanocyte Survival
Since numerous human genes are predicted to be negatively
regulated by miRNAs (Lewis et al., 2005), it is expected that
DICER depletion would affect multiple miRNAs. In our work,
restoring miR-17 in DICER-depleted melanocytes only partially
rescued melanocytes from apoptosis. Thus, additional pathways
are very likely to be involved in melanocyte survival. Epidermal
melanocytes give rise to malignant melanoma, the most aggres-
sive form of skin cancer (Chin et al., 2006). It was recently shown
that BIM expression is inhibited by BRAF signaling in human
melanoma (Cartlidge et al., 2008). Somatic activating mutations
in BRAF are detected in a major fraction of all melanomas (Davies
et al., 2002). Here we identify BIM downregulation within melano-
cytes as residing downstream of MITF. Neither BIM nor the
miR-17 cluster show significant copy number alterations in
melanoma according to an analysis of SNP data from 101 mela-
noma samples (data not shown, False Discovery Rate-adjusted
q-value = 1.0; [Lin et al., 2008]). The pathway consisting of
cAMP/MITF/DICER/miR-17/BIM thus represents a lineage
specific extension of the previously described roles of miR-17
and BIM in cell survival.
miRNA Posttranscriptional Regulation
Expression of specific miRNAs may be transcriptionally regu-
lated upon cell stimulation (Ozsolak et al., 2008; Sempere
et al., 2003). However, like other RNAs, miRNA expression can
be also regulated at the posttranscriptional level in either
a tissue-specific or a developmentally regulated fashion (Winter
et al., 2009). For instance, pre-miR-38, pri-miR-142 and pre let-7
(Ambros et al., 2003; Chang et al., 2009; Heo et al., 2009;Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc. 1001
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Figure 7. The miRNA-17 Cluster Rescues Melanocyte Apoptosis in Cells That Are DICER-Depleted via Inhibition of BIM
(A) Primary human melanocytes were transfected with either siDICER or scrambled siRNA (siScrm). At 48 hr posttransfection, cells were transfected with either
miRNA-17, miRNA-107, siBIM or miRNA/siRNA negative control (cont). Bright field images after 6 days of the indicated oligonucleotide transfections are shown,
along with the average cell number of 3 wells from each treatment (A, right panel). Results are triplicates from one experiment (mean ± s.d.) and are representative
of three independent experiments.
(B) Apoptosis detection assay (TUNEL) was performed on cells from (A). DAPI-stained nuclei appear blue.
(C) Primary human melanocytes from (A) were subject to immunoblot analysis using. Tubulin levels are shown as loading controls.Thomson et al., 2006; Viswanathan et al., 2008; Wu et al., 2009;
Wulczyn et al., 2007) are known cases of post transcriptional
regulation in a tissue and cell type specific manner (Obernosterer
et al., 2006). Analysis of gene expression in primary tumors indi-
cates that the downregulation of miRNAs widely observed in
cancer (Lu et al., 2005) is associated with a failure of the Drosha
processing step (Thomson et al., 2006). The identification of
DICER regulation by MITF within melanocytes suggests that
similar lineage-specific regulatory mechanisms may also exist
in other cell types.
EXPERIMENTAL PROCEDURES
RNA Purification and RT-PCR
Total RNA was purified using Trizol (Invitrogen) according to manufacturer’s
instructions followed by treatment with RNase-free DNase (QIAGEN). For
miRs analysis, 10ng total RNA was used in a TaqMan miR assay, miR expres-
sion was normalized to RNU48 (Applied Biosystems). For mRNAs analysis,
100 ng RNA was subjected to one-step RT-PCR using a QuantiTect RT-PCR1002 Cell 141, 994–1005, June 11, 2010 ª2010 Elsevier Inc.kit (QIAGEN) and iQ SYBRgreen Supermix (Biorad). Primer sequences are
listed in Table S2.miRNA Expression Analysis
miR profiling was done using forsk treated and untreated paired samples from
7 donors. Each sample had 8 RNU44 and 8 RNU48 technical replicate
measurements for quality control and reference normalization. For each
sample, we removed any RNU48 outliers by using the Weisberg t test at
a p-value cutoff of 0.05 (Seely et al., 2003), a method for detecting outliers in
small data sets; miR CT values were then normalized by subtracting the
mean RNU48 CT value of the resulting trimmed set. Some miR expression
values could not be determined by PCR, and we considered only the miRs
whose expression could be assayed in at least three out of seven paired
samples. Fold-changes in miR expression levels after forsk treatment in the
seven samples were pooled together and ranked. Highly ranked miRs were
then found; more precisely, p-values for the rank distribution of miR differential
expression were computed using the hypergeometric test, as in the Redun-
dant siRNA Activity (RSA) analysis (Konig et al., 2007). For each miR, we
also performed a robust paired t test on a trimmed set obtained by removing
at most one outlier sample found by the Weisberg t test at the 5% significance
level (Seely et al., 2003). We obtained a final list of miRs differentially expressed
at the 5% significance level of both hypergeometric test and t test.
Cloning and Luciferase Reporter Assay
A fragment of the DICER promoter 2488 nucleotides upstream to the transcrip-
tion start site (TSS) was amplified from the BAC clone RP11-1143010 (Chil-
dren’s Hospital Oakland Research Institute). KpnI and HindIII used to clone
into PGL-3 basic vector (Promega) upstream of the luciferase reporter gene.
Site directed mutagenesis was performed using the quick change method
according to supplier’s protocols (Stratagene), on two M-Boxes (1384 and
934 nucleotides upstream of the TSS). The constructs were transfected into
UACC62 or 501mel cells in 24-well plates (2 mg DNA/well) using Lipofectamine
2000 (GIBCO BRL) according to the manufacturer’s instructions. Constructs
were cotransfected with the pRL-TK plasmids (Promega). 48 hr after transfec-
tion cells were lysed and assayed using dual-luciferase reagents (Promega).
Promoter activity was normalized to the constitutively expressed Renilla.
Primer sequences for cloning and mutagenesis are listed in Table S2.
Mice and Whole-Mount X-Gal Staining
C57BL/6 mice were crossed with: Dicer(fl/fl) mice (gift from Clifford J. Tabin
[Harfe et al., 2005]), Dopachrome tautomerase (Dct)-LacZ transgenic mice
(a gift of Ian J Jackson [Mackenzie et al., 1997]), K14-Scf transgenic mice
(a gift of T. Kunisada [Kunisada et al., 1998]), Tyr::Cre mice (Delmas et al.,
2003) or Tyr::CreER mice (Bosenberg et al., 2006) or Dct-Cre mice (Guyonneau
et al., 2004). The generated colony was backcrossed with C57BL/6. Samples
were dissected, washed twice with PBS for 5 min at room temperature,
washed and stained as described (Delmas et al., 2003), overnight staining at
37C. Samples were then fixed in 2% Paraformaldehyde at 4C for 30 min.
Immunohistochemistry
Animals were sacrificed by CO2 prior to skin sampling. Samples were formalin
fixed paraffin-embedded. Sections were cut at 4 mm, dried at 37C, deparaffi-
nized in xylene, hydrated in a graded series of ethanol, and subjected to micro-
wave EDTA antigen retrieval. Samples were blocked with 5% BSA/0.5%
Tween-20/PBS, and detection of S100, MITF and DICER were achieved using
mouse anti-DICER (AbCam), rabbit anti-S100 (Dako), mouse monoclonal C5
anti MITF, followed by incubation with Alexa-488 and Alexa-594 conjugated
secondary antibodies (Invitrogen). Nuclear staining was performed with 40-6-
Diamidino-2-phenylindole (DAPI, Vector Laboratories Inc.).Immunofluorescence Image Capturing and Quantification
Images were captured using an Axio Observer A1 microscope and AxioCam
MRc Camera (Carl Zeiss). Camera settings: black and white filter, resolution
of full CD 1388 3 1040 pixels, 403 lens, same exposure time was used for
each channel. Pictures were captured using fluorescence laser (450, 500,
600 nm), converted to the indicated color on AxioVision 4.7.1 and saved as
24 bit RGB. For quantification, the Outline tool was used to trace relevant cells
and using the 8 bit (0–255 gray levels) signal quantification (represents a densi-
tometric mean) in fluorescence on 3 channels (red, green, and blue –DAPI).
Each red/green measurement was normalized to the blue value of the same
traced area. Relative red/green expression values of different cells from the
same picture were then compared. No compression between cells from
different pictures was made, in order to avoid exposure differences.
Melanocyte Apoptosis
Primary melanocytes were seeded on chamber slides (Thermo Fisher Scien-
tific), and transfected as indicated. Six or 8 days post transfection cells were
fixed and used for fluorescent Tunnel staining according to manufacture’s
protocol (R&D Systems).ACCESSION NUMBERS
Data for the miRNA profiling from primary human melanocytes are available at
GEO under accession number GSE21249.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, three tables, and Supplemental References and can be found with this
article online at doi:10.1016/j.cell.2010.05.004.
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